BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33538228)

  • 21. Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway.
    Yan W; Zhang B; Wang H; Mo R; Jiang X; Qin W; Ma L; Lin Z
    Hereditas; 2021 Jun; 158(1):18. PubMed ID: 34074347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis.
    Boppudi S; Bögershausen N; Hove HB; Percin EF; Aslan D; Dvorsky R; Kayhan G; Li Y; Cursiefen C; Tantcheva-Poor I; Toft PB; Bartsch O; Lissewski C; Wieland I; Jakubiczka S; Wollnik B; Ahmadian MR; Heindl LM; Zenker M
    Clin Genet; 2016 Oct; 90(4):334-42. PubMed ID: 26970110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS).
    Martinez-Lopez A; Blasco-Morente G; Perez-Lopez I; Herrera-Garcia JD; Luque-Valenzuela M; Sanchez-Cano D; Lopez-Gutierrez JC; Ruiz-Villaverde R; Tercedor-Sanchez J
    Clin Genet; 2017 Jan; 91(1):14-21. PubMed ID: 27426476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lateralized overgrowth with vascular malformation caused by a somatic PTPN11 pathogenic variant: Another piece added to the puzzle of mosaic RASopathies.
    Mussa A; Turchiano A; Cardaropoli S; Coppo P; Pantaleo A; Bagnulo R; Ranieri C; Iacoviello M; Garganese A; Stella A; Vallero SG; Bertin D; Santoro F; Carli D; Ferrero GB; Resta N
    Genes Chromosomes Cancer; 2022 Nov; 61(11):689-695. PubMed ID: 35778969
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Pagliazzi A; Oranges T; Traficante G; Trapani C; Facchini F; Martin A; Semeraro A; Perrone A; Filippeschi C; Giglio S
    Front Pediatr; 2021; 9():732836. PubMed ID: 34568242
    [No Abstract]   [Full Text] [Related]  

  • 26. Systematised naevus sebaceus resulting from post-zygotic mutation in HRAS.
    Hsu CK; Saito R; Nanda A; Rashidghamat E; Al-Ajmi H; Lee JY; Hide M; McGrath JA
    Australas J Dermatol; 2017 Feb; 58(1):58-60. PubMed ID: 26400620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic PIK3CA mutations in seven patients with PIK3CA-related overgrowth spectrum.
    Yeung KS; Ip JJ; Chow CP; Kuong EY; Tam PK; Chan GC; Chung BH
    Am J Med Genet A; 2017 Apr; 173(4):978-984. PubMed ID: 28328134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth.
    Dalpa E; Gourvas V; Soulitzis N; Spandidos DA
    Med Oncol; 2017 Jan; 34(1):6. PubMed ID: 27943100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [PIK3CA-related overgrowth syndrome (PROS)].
    Venot Q; Canaud G
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S155-S156. PubMed ID: 28577738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: Impact on screening recommendations.
    Faivre L; Crépin JC; Réda M; Nambot S; Carmignac V; Abadie C; Mirault T; Faure-Conter C; Mazereeuw-Hautier J; Maza A; Puzenat E; Collonge-Rame MA; Bursztejn AC; Philippe C; Thauvin-Robinet C; Chevarin M; Abasq-Thomas C; Amiel J; Arpin S; Barbarot S; Baujat G; Bessis D; Bourrat E; Boute O; Chassaing N; Coubes C; Demeer B; Edery P; El Chehadeh S; Goldenberg A; Hadj-Rabia S; Haye D; Isidor B; Jacquemont ML; Van Kien PK; Lacombe D; Lehalle D; Lambert L; Martin L; Maruani A; Morice-Picard F; Petit F; Phan A; Pinson L; Rossi M; Touraine R; Vanlerberghe C; Vincent M; Vincent-Delorme C; Whalen S; Willems M; Marle N; Verkarre V; Devalland C; Devouassoux-Shisheboran M; Abad M; Rioux-Leclercq N; Bonniaud B; Duffourd Y; Martel J; Binquet C; Kuentz P; Vabres P
    Clin Genet; 2023 Nov; 104(5):554-563. PubMed ID: 37580112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative analysis of RAS variants in patients with disorders of somatic mosaicism.
    Claire Hou YC; Evenson MJ; Corliss MM; Mahapatra L; Aldawood A; Carpentieri DF; Chamlin SL; Kulungowski AM; Madan-Khetarpal S; Sebastian J; Pet MA; Coughlin CC; Willing MC; Pearson GD; Setty BA; El-Haffaf Z; Cottrell CE; Parikh BA; Krysiak K; Schroeder MC; Heusel JW; Neidich JA; Cao Y
    Genet Med; 2023 Mar; 25(3):100348. PubMed ID: 36571464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrogenic rests and renal abnormalities in Brachmann-de Lange syndrome.
    Charles AK; Porter HJ; Sams V; Lunt P
    Pediatr Pathol Lab Med; 1997; 17(2):209-19. PubMed ID: 9086528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway.
    Hori Y; Hirose K; Aramaki-Hattori N; Suzuki S; Nakayama R; Inoue M; Matsui T; Kohara M; Toyosawa S; Morii E
    Diagn Pathol; 2020 Jul; 15(1):98. PubMed ID: 32711543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors.
    Polosukhina D; Love HD; Correa H; Su Z; Dahlman KB; Pao W; Moses HL; Arteaga CL; Lovvorn HN; Zent R; Clark PE
    Mol Oncol; 2017 Apr; 11(4):405-421. PubMed ID: 28188683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant congenital melanocytic nevus with vascular malformation and epidermal cysts associated with a somatic activating mutation in BRAF.
    Etchevers HC; Rose C; Kahle B; Vorbringer H; Fina F; Heux P; Berger I; Schwarz B; Zaffran S; Macagno N; Krengel S
    Pigment Cell Melanoma Res; 2018 May; 31(3):437-441. PubMed ID: 29316280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of a uterine broad ligament leiomyoma in a patient with CLOVES syndrome.
    Karpathiou G; Chauleur C; Picot T; Peoc'h M
    Pathol Res Pract; 2020 Dec; 216(12):153285. PubMed ID: 33190013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etiology of Wilms' tumor.
    Sharpe CR; Franco EL
    Epidemiol Rev; 1995; 17(2):415-32. PubMed ID: 8654519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capillary malformations in a child caused by a novel HRAS mutation.
    van Gysel D; de Maeseneer H; Legius E; Brems H
    Pediatr Dermatol; 2024; 41(2):289-291. PubMed ID: 38018302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oculoectodermal syndrome is a mosaic RASopathy associated with KRAS alterations.
    Peacock JD; Dykema KJ; Toriello HV; Mooney MR; Scholten DJ; Winn ME; Borgman A; Duesbery NS; Hiemenga JA; Liu C; Campbell S; Nickoloff BP; Williams BO; Steensma M
    Am J Med Genet A; 2015 Jul; 167(7):1429-35. PubMed ID: 25808193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).
    Vahidnezhad H; Youssefian L; Uitto J
    Exp Dermatol; 2016 Jan; 25(1):17-9. PubMed ID: 26268729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.